Analyzing cancer genetics for better prevention and treatment
Official title: INTERogating Cancer for Etiology, Prevention and Therapy Navigation (INTERCEPTioN)
Run by Mayo Clinic · NCT06008392 · Data updated 2026-11-12
This study is trying to find genetic clues in cancer patients' samples to improve prevention and treatment options for cancer.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Mayo Clinic Academic / other |
| Locations | 5 sites (Scottsdale, Arizona and 4 other locations) |
| Status | Recruiting |
| Started | October 12, 2023 |
| Main results expected | September 2033 |
| Study ends | September 2033 |
| Registry record updated | October 16, 2026 |
| Trial ID | NCT06008392 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals with a confirmed cancer diagnosis who can provide genetic samples and are aware of their condition.
✕Probably not a fit
Patients who are not diagnosed with cancer or unable to provide the necessary samples may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to identify genetic markers and causes of cancer by analyzing patients' DNA, RNA, plasma, tissues, and other samples. It focuses on cancer genetic testing to find specific changes in cancer and normal cells, which may lead to improved prevention, screening, and treatment strategies. Additionally, the study will create a biobank of samples and information to further research in cancer treatment. Participants will undergo pan-genomic testing to discover genetic variants that could enhance cancer management.
Why it matters
Potential benefit: If successful, this study could lead to earlier diagnosis and more effective therapies for cancer patients.
How similar studies have gone: Other studies utilizing genetic testing for cancer have shown promising results, indicating potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: GROUP A: Germline and Somatic Testing * Has Mayo Clinic medical record number * Confirmed cancer diagnosis * Germline and/or somatic tumor/blood testing has been ordered by the clinical provider (or clinical delegate) * Participant aware of cancer diagnosis * Able to provide informed consent * ≥ 18 years old * Ability to provide blood, saliva, bone marrow aspirate or hair follicle sample * Ability to provide archived tissue, if somatic testing has not already been completed * Note: if tissue unavailable participant may still enroll onto the study for the germline collection, or vice versa, if germline has already been completed may still enroll for somatic tissue/blood testing. GROUP B: Germline testing only: * Has Mayo Clinic medical record number * Confirmed cancer diagnosis * Germline testing has been ordered by the clinical provider (or clinical delegate) * Participant aware of cancer diagnosis * Able to provide informed consent * ≥ 18 years old * Ability to provide blood, saliva, or hair follicle sample GROUP C: Somatic tumor testing only: * Has Mayo Clinic medical record number, * Confirmed cancer diagnosis, * Somatic tumor/blood testing has been ordered by the clinical provider (or clinical delegate) * Participant aware of cancer diagnosis, * Able to provide informed consent, * ≥ 18 years old * Ability to provide archived tissue or blood for somatic tumor genomic profiling, if not already completed. Group D: Clinical standard of care germline testing via genetic counselor: * Has Mayo Clinic medical record number, * Standard of care clinical visit with genetic counselor * Confirmed cancer diagnosis, * Germline testing has been ordered by the clinical provider (or clinical delegate) * Participant aware of cancer diagnosis, * Able to provide informed consent, * ≥ 18 years old * Ability to provide blood, saliva, or hair follicle sample Group E: Previous Enrollment in IRB #24-005734, 24-000609, 25-000815, 23-001689, or 24-004810: * Enrolled in any of the following studies: IRB #24-005734, 24-000609, 25-000815, 23-001689, or 24-004810 * Completed Riskguard, OncoExtra, Caris Assure, or Caris MI Profile or any combination of these tests. * Has Mayo Clinic medical record number, * Confirmed cancer diagnosis, * Participant aware of cancer diagnosis * Able to provide informed consent, * ≥ 18 years old Exclusion Criteria: Note: Women who are pregnant or planning to become pregnant can take part in this study. GROUP A: Germline and Somatic testing * Individuals who have situations that would limit compliance with the study requirements * Institutionalized (i.e. Federal Medical Prison) GROUP B: Germline testing only * Individuals who have situations that would limit compliance with the study requirements * Institutionalized (i.e. Federal Medical Prison) * Prior germline genetic testing with a 100+ multi-gene panel within the last 1 year of enrollment Group C: Somatic tumor testing only: * Individuals who have situations that would limit compliance with the study requirements, * Institutionalized (i.e. Federal Medical Prison), Group D: Clinical standard of care germline testing via genetic counselor: * Individuals who have situations that would limit compliance with the study requirements, * Institutionalized (i.e. Federal Medical Prison) Group E: Previous Enrollment in IRB #24-005734, 24-000609, 25-000815, 23-001689, or 24-004810: * Individuals who have situations that would limit compliance with the study requirements, * Institutionalized (i.e. Federal Medical Prison)
Where it's running
-
Mayo Clinic in Arizona
Scottsdale, Arizona, United States Recruiting -
Mayo Clinic in Florida
Jacksonville, Florida, United States Recruiting -
Mayo Clinic in Rochester
Rochester, Minnesota, United States Recruiting -
Mayo Clinic Health System-Eau Claire Clinic
Eau Claire, Wisconsin, United States Recruiting -
Mayo Clinic Health System-Franciscan Healthcare
La Crosse, Wisconsin, United States Recruiting
Study contacts
- Principal investigator: Jewel J. Samadder, MD — Mayo Clinic
- Study coordinator: Cancer Center CRC Team
- Email: Interception@mayo.edu
- Phone: 507-266-7492
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Virtual reality to reduce psychological symptom burden during cancer treatment
This trial will try virtual reality sessions to reduce anxiety, depression, and adjustment symptoms for adults receiving cancer treatment.
-
Connecting underrepresented populations to clinical trials at Ohio State University
This study is trying to find better ways to connect racial and ethnic minorities to cancer clinical trials at Ohio State University to help them participate more.
-
Virtual group therapy to improve psychological wellbeing in cancer patients
This study is testing if virtual group therapy that combines acceptance and commitment therapy with compassion can help improve the mental wellbeing of cancer patients.
-
Community-based exercise program for cancer survivors
This study tests a 12-week exercise program for cancer survivors to see if it helps them feel better and improves their quality of life.
-
New blood and urine tests for cancer screening
This study is testing new blood and urine tests for cancer screening to see how well they work in people without known cancer and how different health factors might affect the results.
-
Telemedicine support for older cancer patients in underserved communities
This study tests whether using telemedicine to provide extra support can help older cancer patients in underserved communities feel better and have fewer hospital visits compared to standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.